Study on the function and mechanism of CXCR5+PD1+CD4+ T (Tfh-like) cell subsets in the anti-tumor immunity of glioma infiltration

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047764

Enrollment

Unknown

Registered

2021-06-26

Start date

2021-07-30

Completion date

Unknown

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

case series:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: More than 2 pathologists re-read the pictures together and confirmed the diagnosis as malignant glioma.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
Activation and killing of CD8+;Activation and killing of natural killer cell;Activation and killing of B cell;	—

Countries

China

Contacts

Public ContactLiu Xindong

The First Affiliated Hospital of Army Medical University

xindongliu@hotmail.com+86 13718549578

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026